Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.810
-0.075-1.54%
Volume:8.23M
Turnover:39.48M
Market Cap:30.22B
PE:6.41
High:4.930
Open:4.930
Low:4.755
Close:4.885
52wk High:6.336
52wk Low:4.211
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:1.51
T/O Rate:0.13%
Dividend:0.22
Dividend Rate:4.53%
EPS(LYR):0.751
ROE:8.96%
ROA:2.91%
PB:0.50
PE(LYR):6.41
PS:0.10

Loading ...

CHINARES PHARMA Keeps Share Base Unchanged at 6.28 Billion in March 2026, Confirms Public Float Compliance

Bulletin Express
·
Apr 01

A Look At China Resources Pharmaceutical Group (SEHK:3320) Valuation After 2025 Results And Higher Dividend Proposal

Simply Wall St.
·
Mar 30

CHINARES PHARMA Subsidiary CR Pharmaceutical Commercial Completes RMB1.80 Billion First-Tranche 2026 Bond Issue at 1.70% Coupon

Bulletin Express
·
Mar 27

CHINARES PHARMA Subsidiary Successfully Issues 1.8 Billion Yuan Corporate Bonds

Stock News
·
Mar 27

China Resources Pharmaceutical affiliate CR Pharmaceutical Commercial issues 2026 corporate bonds; RMB1.8 billion tranche sets 1.70% coupon

Reuters
·
Mar 27

CLSA Maintains Outperform Rating on China Resources Pharmaceutical, Raises Target Price to HK$7.2

Stock News
·
Mar 27

CMSC International Raises CHINARES PHARMA (03320) Target Price to HK$6.3, Keeps "Add" Rating

Stock News
·
Mar 27

Stock Track | CHINARES PHARMA Soars 5.25% Intraday on Strong Earnings Results and Positive Outlook

Stock Track
·
Mar 27

CHINARES PHARMA Shares Extend Rally with Another 5% Gain

Stock News
·
Mar 27

CHINARES PHARMA Subsidiary Double-Crane Issues Up to RMB 1 Billion Corporate Bonds

Stock News
·
Mar 26

CR Pharma’s Subsidiary CR Double-Crane Issues RMB1.00 Billion Three-Year Bonds at 1.65% Coupon

Bulletin Express
·
Mar 26

CR Double-Crane issues 2026 corporate bonds; principal totals up to RMB1 billion at 1.65% coupon rate

Reuters
·
Mar 26

UBS Adjusts CHINARES PHARMA Target Price to HK$6.9, Citing In-Line Revenue and Above-Expectation Net Profit

Stock News
·
Mar 26

Stock Track | CHINARES PHARMA Soars 6.24% in Morning Session on Strong Annual Results with 20.73% Profit Jump

Stock Track
·
Mar 26

CHINARES PHARMA Shares Surge Over 6% in Morning Trading Following 20.73% Jump in Annual Net Profit

Deep News
·
Mar 26

BUZZ-China Resources Pharma hits more than 4-month peak on higher FY profit, dividend

Reuters
·
Mar 25

Stock Track | CHINARES PHARMA Soars 5.17% Intraday on Strong FY2025 Results That Beat Estimates

Stock Track
·
Mar 25

CHINARES PHARMA Reports Fiscal Year Profit Increase of 20.73% to 4.045 Billion Yuan

Stock News
·
Mar 25

China Resources Pharma proposes final dividend of RMB 0.122 per share

Reuters
·
Mar 25

China Resources Pharmaceutical - FY Profit Attributable RMB4.05 Bln

THOMSON REUTERS
·
Mar 25